pentobarbital will reduce the extent or result of cobimetinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay clear of coadministration. Potent or reasonable CYP3A inducers might minimize cobimetinib systemic exposure by >eighty% and cut down its efficacy.DRUG ABUSE AND DEPENDENCE Pentobarbital sodium injection is su